Bloomberg News

Zealand Pharma’s Lixisenatide Effective Mornings and Evenings

December 10, 2011

Dec. 8 (Bloomberg) -- Zealand Pharma A/S said a study has shown both morning and evening administration of its once-daily diabetes drug lixisenatide significantly cut blood sugar levels.

To contact the editor responsible for this story: Frances Schwartzkopff at fschwartzko1@bloomberg.net


Steve Ballmer, Power Forward
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus